Biopharmaceuticals
Generics
FDA
News Release - January 31, 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
Source: Celltrion
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.